JAN 28, 2020 12:52 PM PST

A Rare Genetic Disorder is Effectively Treated With Modified Stem Cells

WRITTEN BY: Carmen Leitch

An international team of researchers has completed a clinical trial that used stem cell gene therapy to treat a rare genetic disorder called X-linked chronic granulomatous disease (X-CGD) in nine patients. Six of these individuals have been able to stop treatment because their disease is in remission. X-CGD typically causes recurrent infections, long hospital stays, and shortens a patient's life; this successful clinical trial can change that. The work has been reported in Nature Medicine.

"With this gene therapy, you can use a patient's own stem cells instead of donor cells for a transplant," said the senior study author Dr. Donald Kohn, a member of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA. "This means the cells are perfectly matched to the patient and it should be a much safer transplant, without the risks of rejection."

Chronic granulomatous disease results from a genetic mutation in any of five genes that act to assist white blood cells that destroy invading bacteria and fungus with a chemical burst. Patients with one of those five mutations lack that chemical burst, which makes them far more susceptible to infections than healthy individuals. The infections they get are also more severe and may be life-threatening; they can cause abscesses in organs including the brain. In the case of X-CGD, the gene mutation is carried by a gene that sits on the X chromosome, and only impacts males.

Preventive antibiotics are used by CGD patients to stop infection, but a bone marrow transplant can be used to treat the disease - hematopoietic stem cells in the bone marrow give rise to new white blood cells that are not impacted by the genetic mutation. Transplants are challenging, however; healthy donors are hard to find and there is a chance of rejection, for example.

At left, image shows white blood cells (red) from one of the X-CGD clinical trial participants before gene therapy. At right, after gene therapy, white blood cells from the same patient show the presence of the chemicals (blue) needed to attack and destroy bacteria and fungus. Credit:  UCLA Broad Stem Cell Research Center/Nature Medicine

"Patients can certainly get better with these bone marrow transplants, but it requires finding a matched donor and even with a match, there are risks," Kohn said. 

In this new approach, hematopoietic stem cells were taken from X-CGD patients and in the lab, the cells' genomes were edited to correct the mutation. These genetically modified stem cells were then put back into the patients’ bodies. 

Two patients did not survive for more than a few months after they received the stem cell therapy, but they had been fighting very serious infections even before they received the treatment. The remaining patients have not gotten any new infections, and six of the seven ceased taking preventive antibiotics. 

"None of the patients had complications that you might normally see from donor cells and the results were as good as you'd get from a donor transplant -- or better," Kohn said.

Four new patients have gotten this treatment since the Nature Medicine paper was published, and all of them are free of new infections and have not had complications.

Kohn and colleagues already pioneered a similar treatment for a form of severe combined immune deficiency that has effectively cured the diseases in over fifty babies. Now, the team wants to create similar approaches to treat other types of CGD.

"Beyond CGD, there are also other diseases caused by proteins missing in white blood cells that could be treated in similar ways," Kohn added.


Sources: AAAS/Eurekalert! via University of California – Los Angeles Health Sciences, Nature Medicine

About the Author
BS
Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
AUG 01, 2022
Cell & Molecular Biology
Gut Microbes that Release Histamine Worsen IBS Pain
AUG 01, 2022
Gut Microbes that Release Histamine Worsen IBS Pain
When the white blood cells in our bodies encounter a pathogen, they can release a molecule called histamine, which can h ...
AUG 20, 2022
Technology
Biofilm can Convert Energy from Evaporation into Electricity
AUG 20, 2022
Biofilm can Convert Energy from Evaporation into Electricity
In a recent study published in Nature Communications, a team of researchers at the University of Massachusetts (UMass) A ...
AUG 15, 2022
Microbiology
Untangling the Links Between Alcohol, Liver Disease & Gut Microbes
AUG 15, 2022
Untangling the Links Between Alcohol, Liver Disease & Gut Microbes
Chronic alcohol use is a serious health problem, and a major contributor to liver disease and mortality. The gut microbi ...
SEP 08, 2022
Genetics & Genomics
Evidence of Trauma in DNA Could Predict Who is Most at Risk
SEP 08, 2022
Evidence of Trauma in DNA Could Predict Who is Most at Risk
A recent study has outlined the findings from a 17-year study of almost 500 people who experienced trauma in childhood. ...
SEP 19, 2022
Genetics & Genomics
Some Gene Variants May Encourage Active or Sedentary Lifestyles
SEP 19, 2022
Some Gene Variants May Encourage Active or Sedentary Lifestyles
There is still a lot of debate about how much a person's genes influence their behavior. Twin studies are one way to hel ...
SEP 11, 2022
Drug Discovery & Development
Effects of Ketamine in Mice Depend on Sex of Human Experimenter
SEP 11, 2022
Effects of Ketamine in Mice Depend on Sex of Human Experimenter
Researchers found that mice more consistently experience antidepressant effects from ketamine when administered by men a ...
Loading Comments...